
    
      Objectives: To compare the effect of vitamin D3 on modifying the disease severity in CF and
      non CF bronchiectasis pediatric patients.

      Patients and Methods: This was a randomized clinical trial evaluating the role of oral
      vitamin D3 supplementation for 6 months in forty patients with CF and non CF bronchiectasis
      under the age of 18 years with vitamin D deficiency or insufficiency . The primary outcome
      was to reach the sufficient Vitamin D level. The secondary outcome was to follow up the
      frequency of pulmonary exacerbations and lung function after vitamin D3 supplementation.
    
  